Literature DB >> 23970136

Effects of exercise and lifestyle intervention on cardiovascular function in CKD.

Erin J Howden1, Rodel Leano, William Petchey, Jeff S Coombes, Nicole M Isbel, Thomas H Marwick.   

Abstract

BACKGROUND AND OBJECTIVES: CKD is associated with poor cardiorespiratory fitness (CRF). This predefined substudy determined the effect of exercise training and lifestyle intervention on CRF and explored the effect on cardiovascular risk factors and cardiac and vascular function. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Between February 2008 and March 2010, 90 patients with stage 3-4 CKD were screened with an exercise stress echocardiogram before enrollment. Patients (n=83) were randomized to standard care (control) or lifestyle intervention. The lifestyle intervention included multidisciplinary care (CKD clinic), a lifestyle program, and aerobic and resistance exercise training for 12 months. CRF (peak Vo2), left ventricular function, arterial stiffness, anthropometric, and biochemical data were collected at baseline and 12 months.
RESULTS: Ten percent of randomized patients had subclinical myocardial ischemia at screening and completed the study without incident. There was no baseline difference among 72 patients who completed follow-up (36 in the lifestyle intervention group and 36 in the control group). The intervention increased peak Vo2 (2.8±0.7 ml/kg per minute versus -0.3±0.9 ml/kg per minute; P=0.004). There was small weight loss (-1.8±4.2 kg versus 0.7±3.7 kg; P=0.02) but no change in BP or lipids. Diastolic function improved (increased e' of 0.75±1.16 cm/s versus -0.47±1.0 cm/s; P=0.001) but systolic function was well preserved and did not change. The change in arterial elastance was attenuated (0.11±0.76 mmHg/ml versus 0.76±0.96 mmHg/ml; P=0.01). Δ peak Vo2 was associated with group allocation and improved body composition.
CONCLUSIONS: Exercise training and lifestyle intervention in patients with CKD produces improvements in CRF, body composition, and diastolic function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23970136      PMCID: PMC3805077          DOI: 10.2215/CJN.10141012

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  38 in total

1.  Aging, habitual exercise, and dynamic arterial compliance.

Authors:  H Tanaka; F A Dinenno; K D Monahan; C M Clevenger; C A DeSouza; D R Seals
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

2.  Noninvasive single-beat determination of left ventricular end-systolic elastance in humans.

Authors:  C H Chen; B Fetics; E Nevo; C E Rochitte; K R Chiou; P A Ding; M Kawaguchi; D A Kass
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

3.  Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease.

Authors:  Peter A McCullough; Keisha R Sandberg; Steven Borzak; Michael P Hudson; Mukesh Garg; Harold J Manley
Journal:  Am Heart J       Date:  2002-08       Impact factor: 4.749

4.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

5.  Effect of a cardiac rehabilitation program on left ventricular diastolic function and its relationship to exercise capacity in patients with coronary heart disease: experience from a randomized, controlled study.

Authors:  Cheuk-Man Yu; Leonard Sheung-Wai Li; Man-Fai Lam; David Chung-Wah Siu; Raymond Kin-Man Miu; Chu-Pak Lau
Journal:  Am Heart J       Date:  2004-05       Impact factor: 4.749

6.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

Review 7.  Exercise training in chronic kidney disease patients.

Authors:  Erin J Howden; Robert G Fassett; Nicole M Isbel; Jeff S Coombes
Journal:  Sports Med       Date:  2012-06-01       Impact factor: 11.136

8.  Exercise training improves conduit vessel function in patients with coronary artery disease.

Authors:  Jennifer H Walsh; William Bilsborough; Andrew Maiorana; Matthew Best; Gerard J O'Driscoll; Roger R Taylor; Daniel J Green
Journal:  J Appl Physiol (1985)       Date:  2003-07

9.  Beneficial effects of water-based exercise in patients with chronic kidney disease.

Authors:  Ulle Pechter; Mai Ots; Siiri Mesikepp; Kersti Zilmer; Tiiu Kullissaar; Tiiu Vihalemm; Mihkel Zilmer; Jaak Maaroos
Journal:  Int J Rehabil Res       Date:  2003-06       Impact factor: 1.479

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  53 in total

1.  The accumulation of healthy lifestyle behaviors prevents the incidence of chronic kidney disease (CKD) in middle-aged and older males.

Authors:  Ryoma Michishita; Takuro Matsuda; Shotaro Kawakami; Akira Kiyonaga; Hiroaki Tanaka; Natsumi Morito; Yasuki Higaki
Journal:  Environ Health Prev Med       Date:  2016-01-21       Impact factor: 3.674

Review 2.  Strategies for Achieving Healthy Vascular Aging.

Authors:  Kristen L Nowak; Matthew J Rossman; Michel Chonchol; Douglas R Seals
Journal:  Hypertension       Date:  2018-01-08       Impact factor: 10.190

3.  Misclassification of obesity in CKD: appearances are deceptive.

Authors:  Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 8.237

Review 4.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

Review 5.  Cognitive and physical function in chronic kidney disease.

Authors:  Daniel E Weiner; Stephen L Seliger
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

6.  Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease.

Authors:  David M Small; Kassia S Beetham; Erin J Howden; David R Briskey; David W Johnson; Nicole M Isbel; Glenda C Gobe; Jeff S Coombes
Journal:  Redox Rep       Date:  2017-01-11       Impact factor: 4.412

7.  Short-term aerobic exercise and vascular function in CKD stage 3: a randomized controlled trial.

Authors:  Samuel Headley; Michael Germain; Richard Wood; Jyovani Joubert; Charles Milch; Elizabeth Evans; Anthony Poindexter; Allen Cornelius; Britton Brewer; Linda S Pescatello; Beth Parker
Journal:  Am J Kidney Dis       Date:  2014-04-26       Impact factor: 8.860

8.  Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease.

Authors:  Shannon B Fadaee; Kassia S Beetham; Erin J Howden; Tony Stanton; Nicole M Isbel; Jeff S Coombes
Journal:  Redox Rep       Date:  2016-04-19       Impact factor: 4.412

9.  Cardiac function is preserved following 4 weeks of voluntary wheel running in a rodent model of chronic kidney disease.

Authors:  James M Kuczmarski; Christopher R Martens; Jahyun Kim; Shannon L Lennon-Edwards; David G Edwards
Journal:  J Appl Physiol (1985)       Date:  2014-07-24

10.  Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.

Authors:  Megan Rossi; David W Johnson; Mark Morrison; Elaine M Pascoe; Jeff S Coombes; Josephine M Forbes; Cheuk-Chun Szeto; Brett C McWhinney; Jacobus P J Ungerer; Katrina L Campbell
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-15       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.